Fate Therapeutics Inc (FATE)

Operating Expenses

$33.22M

Quarterly · Period ending: · USD

FATE logo

FATE Operating Expenses

Latest reported$33.22M
FATE Quarterly Operating Expenses ($4.18M → $33.22M)
High-resolution chart · PNG

FATE operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Fate Therapeutics Inc Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
33,216,000
31,381,000
36,090,000
10,638,000
35,054,000
13,773,000
46,469,000
20,801,000
47,134,000
48,172,000
44,866,000
48,483,000
22,622,000
21,943,000
21,584,000
21,555,000
20,351,000
20,742,000
16,936,000
15,718,000
12,168,000
12,500,000
10,313,000
8,351,000
7,503,000
7,729,000
31,880,000
29,548,000
26,901,000
23,078,000
18,402,000
17,718,000
20,632,000
15,080,000
13,271,000
11,366,000
10,596,000
10,998,000
8,681,000
9,415,000
9,031,000
9,238,000
7,988,000
7,354,000
7,547,000
7,324,000
5,943,000
5,984,000
6,040,000
6,937,000
4,902,000
5,357,000
4,559,000
3,828,000
4,687,000
4,178,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.